Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer

ÖZYİĞİT G. , HÜRMÜZ P. , YÜCE D. , Akyol F.

WORLD JOURNAL OF CLINICAL ONCOLOGY, vol.10, no.8, pp.283-292, 2019 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 8
  • Publication Date: 2019
  • Doi Number: 10.5306/wjco.v10.i8.283
  • Title of Journal : WORLD JOURNAL OF CLINICAL ONCOLOGY
  • Page Numbers: pp.283-292
  • Keywords: Prostate cancer, Androgen deprivation therapy, Radiotherapy, Testosterone, Castration, ANDROGEN-DEPRIVATION THERAPY, SERUM TESTOSTERONE, SUPPRESSION, RADIOTHERAPY, TRIAL, LEUPROLIDE, DURATION

Abstract

BACKGROUND